The AMES Rehabilitation Therapy Device utilizes patented therapeutic technology, which enhances specific sensory input and motor output connections in the brain for individuals recovering from stroke and other neurological disorders.

The AMES therapy differs from conventional and other robotic approaches in that it treats specific and localized impairments, such as spasticity or paresis in a particular muscle, rather than global behaviors, such as gait or targeted reaching. AMES also is unique in coupling localized sensory stimulation with assisted movement.

AMES is an acronym describing the technology underlying the AMES Rehabilitation Therapy Medical Device (Assisted Movement with Enhanced Sensation). This patented* technology combines assisted movement—a new, rapidly developing area of neurorehabilitation—with muscle vibration, a unique technology for enhancing movement sensation.

The AMES technique and device were designed to induce functional plasticity in the patient’s central nervous system by the repetitive and synchronous activation of cortico-motor and cortico-sensory neurons.

Pairing particular directions of assisted movement with the vibration of specific muscles, it is now possible to reduce neurological impairments that prevent functional movement.

*U.S. Patent No. 6,878,122; U.S. Patent No. 7,563,234; U.S. Patent No. 7,566,311